Our study was approved by the Ethics Committee of Anhui Women and Childrens Medical Center (Approval No: 2023-011), in accordance with the ethical standards of the Helsinki declaration and its later amendments or comparable ethical standards
Patient had stopped semaglutide use 36 days prior to post-semaglutide scan
Severe Gastrointestinal Disease: Mounjaro (tirzepatide) injection is associated with gastrointestinal side effects, such as nausea, diarrhea, vomiting, constipation, and stomach pain, and can sometimes be severe
Office-Use Orders (503B): You may either use our portal (see link above), send a fax to (832) 678-4419, call in a prescription at (346) 229-5385, or email your order to [email protected]
PlexusDx provides access to compounded oral GLP-1 therapy tailored to individual metabolic profiles
Self-monitoring in blood glucose is not needed in order to adjust the dose of Orsema